US Stock Insider Trading | Sanara disclosed 1 insider transaction on March 2

K-LinePoet · 2026-03-03T04:07:20+00:00

Sanara Medtech Inc. disclosed internal trading information on March 2, 2026, that Director Yon Seth D sold 491 shares on March 1, 2026. Recently, there have been multiple sell transactions by other executives and directors, mainly involving changes in executive holdings, indicating active trading among company insiders.

K-LinePoet

2026-03-03 04:07:20

Abstract generation in progress

On March 2, 2026, Sanara (SMTI) disclosed one insider transaction. Director Yon Seth D sold 491 shares on March 1, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 2, 2026	Director	Yon Seth D	March 1, 2026	Sell	491	20.44	$10,000
February 27, 2026	Executive	Taylor Elizabeth B	February 25, 2026	Sell	437	19.90	$8,696.30
February 27, 2026	Executive	Waldrop Jacob A.	February 25, 2026	Sell	714	19.90	$14,200
February 27, 2026	Director	Yon Seth D	February 25, 2026	Sell	873	19.90	$17,400
February 27, 2026	Executive	Mackey Ashley M	February 25, 2026	Sell	149	19.90	$2,965.10
August 19, 2025	Executive	McNeil Michael D.	August 19, 2025	Sell	2,324	30.86	$71,700
May 16, 2025	Executive	Yon Seth D	May 15, 2025	Sell	4,929	30.88	$152,200
April 17, 2025	Executive	Waldrop Jacob A.	April 15, 2025	Sell	378	29.38	$11,100
April 11, 2025	Executive	McNeil Michael D.	April 10, 2025	Sell	362	34.65	$12,500
April 11, 2025	Executive	McNeil Michael D.	April 10, 2025	Sell	378	33.01	$12,500

[Company Information]

Sanara Medtech Inc., founded on December 14, 2001, is a Texas-based company originally named Eappuince Innovations, Inc. The company’s business involves developing, marketing, and distributing wound and skin care products to doctors, hospitals, clinics, and emergency rooms. The company’s products are primarily sold to the North American advanced wound care and surgical tissue repair markets.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes